These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7127301)

  • 1. Clonal drift of cell surface, melanogenic, and experimental metastatic properties of in vivo-selected, brain meninges-colonizing murine B16 melanoma.
    Miner KM; Kawaguchi T; Uba GW; Nicolson GL
    Cancer Res; 1982 Nov; 42(11):4631-8. PubMed ID: 7127301
    [No Abstract]   [Full Text] [Related]  

  • 2. Selection of malignant melanoma variant cell lines for ovary colonization.
    Brunson KW; Nicolson GL
    J Supramol Struct; 1979; 11(4):517-28. PubMed ID: 544929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
    Miner KM; Klostergaard J; Granger GA; Nicolson GL
    J Natl Cancer Inst; 1983 Apr; 70(4):717-24. PubMed ID: 6339778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases.
    Poste G; Doll J; Brown AE; Tzeng J; Zeidman I
    Cancer Res; 1982 Jul; 42(7):2770-8. PubMed ID: 7083167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of arrest, survival, and growth of selected metastatic variant cell lines.
    Nicolson GL; Brunson KW; Fidler IJ
    Cancer Res; 1978 Nov; 38(11 Pt 2):4105-11. PubMed ID: 359132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity in growth inhibition by beta-trans-retinoic acid of metastatic B16 melanoma clones and in vivo-selected cell variant lines.
    Lotan R; Nicolson GL
    Cancer Res; 1979 Dec; 39(12):4767-71. PubMed ID: 498105
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
    Irimura T; Gonzalez R; Nicolson GL
    Cancer Res; 1981 Sep; 41(9 Pt 1):3411-8. PubMed ID: 7260906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth characteristics of clonal cell populations constituting a B16 melanoma metastasis model system.
    Stackpole CW; Alterman AL; Fornabaio DM
    Invasion Metastasis; 1985; 5(3):125-43. PubMed ID: 3888909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in cell density associated with differences in lung-colonizing ability of B16 melanoma cells.
    Baniyash M; Netanel T; Witz IP
    Cancer Res; 1981 Feb; 41(2):433-7. PubMed ID: 7448787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of experimental lung metastases by cultured B16 melanoma cells treated with (+/-)-1,2-bis(3,5-dioxopiperazin-1-y)propane (ICRF-159).
    Lazo JS; Ingber DE; Sartorelli AC
    Cancer Res; 1978 Aug; 38(8):2263-70. PubMed ID: 667822
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of a new melanoma model in C57BL/6 mice.
    Berkelhammer J; Oxenhandler RW; Hook RR; Hennessy JM
    Cancer Res; 1982 Aug; 42(8):3157-63. PubMed ID: 7093959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of glycoconjugates in metastatic melanoma blood-borne arrest and cell surface properties.
    Irimura T; Nicolson GL
    J Supramol Struct Cell Biochem; 1981; 17(4):325-36. PubMed ID: 7328676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous in vitro sensitivities of metastatic B16 melanoma sublines and clones to retinoic acid or BCNU.
    Nicolson GL; Lotan R; Rios A
    Cancer Treat Rep; 1981; 65 Suppl 2():71-4. PubMed ID: 7346150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different deficiencies in the prevention of tumorigenic-low-metastatic murine K-1735b melanoma cells from producing metastases.
    Aukerman SL; Price JE; Fidler IJ
    J Natl Cancer Inst; 1986 Oct; 77(4):915-24. PubMed ID: 3463821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relation between immunogenicity and differentiation of metastasis in an experimental murine melanoma].
    Heinen E; Beckers J; Desaive C; Lennes G; Simar L
    C R Seances Soc Biol Fil; 1982; 176(2):223-6. PubMed ID: 6212110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of protein phosphorylation in metastatic variants of B16 melanoma.
    Greig RG; Caltabiano L; Reid R; Feild J; Poste G
    Cancer Res; 1983 Dec; 43(12 Pt 1):6057-65. PubMed ID: 6640547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell surface properties of B16 melanoma variants with differing metastatic potential.
    Raz A; McLellan WL; Hart IR; Bucana CD; Hoyer LC; Sela BA; Dragsten P; Fidler IJ
    Cancer Res; 1980 May; 40(5):1645-51. PubMed ID: 7370996
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties.
    Poste G; Doll J; Hart IR; Fidler IJ
    Cancer Res; 1980 May; 40(5):1636-44. PubMed ID: 7370995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Melanogenesis of malignant melanoma cells--comparative studies on low-pigmented and high-pigmented cell lines of B16 mouse melanoma (author's transl)].
    Koike M
    Igaku Kenkyu; 1978 Dec; 48(8):619-38. PubMed ID: 747089
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent observations on the pathogenesis of cancer metastasis.
    Fidler IJ; Hart IR
    Prog Clin Biol Res; 1982; 85 Pt B():601-19. PubMed ID: 6750636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.